Neuropsychological assessment has featured prominently over the past 30 years in the
characterization of dementia associated with Alzheimer disease (AD). Clinical …

Sex differences in neurocognitive abilities have been extensively explored both in the
healthy population and in many disorders. Until recently, however, little work has examined …

Background: Although memory impairment is the main symptom of Alzheimer's disease
(AD), language impairment can be an important marker. Relatively few studies of language …

Background To evaluate the interest of using automatic speech analyses for the assessment
of mild cognitive impairment (MCI) and early-stage Alzheimer's disease (AD). Methods …

Objective: Berries are high in flavonoids, especially anthocyanidins, and improve cognition
in experimental studies. We prospectively evaluated whether greater long‐term intakes of …

Normative data stratified by three levels of age (16–59, 60–79, and 80–95 years) and three
levels of education (0–8, 9–12, and 13–21 years) are presented for phonemic verbal fluency …

Introduction Amyloid-related decline in semantic memory was recently shown to be
observable in the preclinical period of Alzheimer's disease. Cognitive composites designed …

A meta-analysis of 153 studies with 15,990 participants was conducted to compare the
magnitude of deficits upon tests of phonemic and semantic fluency for patients with …

Importance Assessing the ability of Alzheimer disease neuroimaging markers to predict
short-term cognitive decline among clinically normal (CN) individuals is critical for upcoming …

Objectives: To validate a simple bedside test battery designed to detect mild dementia and
differentiate AD from frontotemporal dementia (FTD). Methods: Addenbrooke's Cognitive …